Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
184.49
USD
+1.88 (+1.03%)
Official Closing Price
Updated: 7:50 PM EDT, Apr 9, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Today 9:18 EDT
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a ...
Tags
Market News
Small Cap
AFMD
From
Benzinga
Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline?
Today 7:03 EDT
One of the three clearly has the most upside potential.
Tags
GSK
VIR
LLY
From
Motley Fool
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
April 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
IBB
VCEL
Biotech
From
Benzinga
Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes
April 09, 2021
Provention Bio Inc(NASDAQ:PRVB)revealed it had received a notificationon April 2 from the FDA stating that ...
Tags
Diabetes
General
LLY
From
Benzinga
Global COVID-19 cases top 133 million as Brazil and India become flashpoints
April 08, 2021
The number of global confirmed cases of the coronavirus-borne illness COVID-19 climbed above 133 million on Thursday and the death toll edged closer to 3 million, as India and Brazil became flashpoints...
Tags
SPX
DJIA
PFE
From
MarketWatch
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data
April 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Biotech
LHDX
AUPH
From
Benzinga
Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal
April 08, 2021
Eli Lilly And Co(NYSE:LLY) andIncyte Corporation(NASDAQ:INCY)have reported ...
Tags
News
Health Care
Benzinga
From
Benzinga
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
April 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ARDX
IMMP
FGEN
From
Benzinga
Is Silicon Valley Replacing Big Pharma In Neuroscience?
April 06, 2021
The following article is sponsored by Mind Cure. The information contained in this article in no way represents investment advice or ...
Tags
General
CMPS
LLY
From
Benzinga
Noteworthy ETF Outflows: XLV, ABT, MDT, LLY
April 05, 2021
Symbols mentioned in this story: XLV, ABT, MDT, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Better Buy for 2021: Pfizer or Gilead?
April 05, 2021
In a post-pandemic world, one company has the lower valuation and higher dividend yield to be a success.
Tags
GILD
Market News
SPY
From
Motley Fool
The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight
April 03, 2021
Biotech stocks ended the holiday-shortened week ended April 1 in the green, catalyzed by the broader market rebound and a slew of ...
Tags
TCRR
FDA
pharmaceuticals
From
Benzinga
Fortress Biotech's Partner Firm Expands Footprint In Dermatology With Qbrexza Acquisition
April 01, 2021
Fortress Biotech Inc's(NASDAQ:FBIO) partner companyJourney Medical Corporationhasagreed to ...
Tags
Small Cap
Axillary Hyperhidrosis
Market News
From
Benzinga
Could Pfizer's and Lilly's Long-Awaited Osteoarthritis Drug Flop?
March 31, 2021
It looks like an uphill battle for tanezumab.
Tags
PFE
LLY
Market News
From
Motley Fool
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
March 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
BNTX
PIRS
MRK
From
Benzinga
Why Humanigen Stock Is Skyrocketing Today
March 29, 2021
The company's investigational coronavirus treatment could hit the market soon.
Tags
LLY
Market News
GILD
From
Motley Fool
Eli Lilly-Vir Bamlanivimab-VIR-7831 Combo Reduces Viral Load By 70% In Low-Risk COVID-19 Patients
March 29, 2021
Eli Lilly And Co(NYSE:LLY),Vir Biotechnology Inc(NASDAQ:VIR), andGlaxoSmithKline ...
Tags
News
Health Care
Benzinga
From
Benzinga
This Stalwart's Growth Story Isn't Over Yet
March 29, 2021
It's a big-name pharma with a storied history, but Eli Lilly still has plenty of room left to run.
Tags
BMY
ABBV
JNJ
From
Motley Fool
2 Surefire Stocks to Buy for a Biden Bull Market
March 27, 2021
These two healthcare stocks could be big winners in a post-pandemic economy.
Tags
BIIB
SNY
LLY
From
Motley Fool
Looking Into Eli Lilly's Return On Capital Employed
March 26, 2021
Looking at Q4, Eli Lilly (NYSE:LLY) earned $1.99 billion, a 55.84% increase from the preceding quarter. Eli Lilly ...
Tags
BZI/ROCE
Markets
Market News
From
Benzinga
A Peek Into The Markets: US Stock Futures Gain Ahead Of Economic Reports
March 26, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones added around 200 200 points in the ...
Tags
Market News
TSLA
PRGS
From
Benzinga
5 Stocks To Watch For March 26, 2021
March 26, 2021
Some of the stocks that may grab investor focus today are: Progress Software Corp (NASDAQ: PRGS) reported better-than-expected ...
Tags
Earnings
LLY
Trading Ideas
From
Benzinga
Pfizer And Eli Lilly's Osteoarthritis Drug Rejected By FDA Panel As Too Risky
March 26, 2021
An expert panel of theU.S. Food and Drug Administrationhas rejected Pfizer Inc. (NYSE: PFE) and Eli Lilly and ...
Tags
tanezumab
Market News
Biotech
From
Benzinga
Interesting LLY Put And Call Options For May 7th
March 25, 2021
Investors in Lilly (Eli) & Co (LLY) saw new options become available today, for the May 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LLY options chain for...
Tags
Stocks
From
Market News Video
The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
March 25, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
APOP
SGTX
RDUS
From
Benzinga
SciSparc Might Become The Next GW Pharmaceuticals
March 24, 2021
With the Jazz Pharmaceuticals buyout of GW Pharmaceuticals, biotech marijuana stocks are in the spotlight and one of particular interest is SciSparc Ltd.
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping
March 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Biotech
ODT
DVAX
From
Benzinga
Will Another Alzheimer's Disease Drug Bite the Dust After Lilly's Latest Results?
March 24, 2021
Investors aren't optimistic after Eli Lilly reported mixed results from a phase 2 study of its Alzheimer's disease candidate, donanemab.
Tags
BIIB
Market News
LLY
From
Motley Fool
Pfizer Starts Early-Stage Study Of Oral Antiviral COVID-19 Drug
March 23, 2021
Pfizer Inc(NYSE:PFE)has started an early-stage U.S. trialof an oral COVID-19 antiviral therapy, dubbed as ...
Tags
News
Health Care
Benzinga
From
Benzinga
Global case tally for COVID-19 nears 124 million as U.S. health experts question AstraZeneca trial data
March 23, 2021
The global case tally for the coronavirus-borne illness COVID-19 crept closer to 124 million on Tuesday, as U.S. health officials raised concerns about results from a trial of AstraZeneca PLC's vaccine...
Tags
UK:AZN
CH:ROG
REGN
From
MarketWatch
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.